Second generation of 2H-benzimidazole 1,3-dioxide derivatives as anti-trypanosomatid agents: Synthesis, biological evaluation, and mode of action studies

被引:33
作者
Boiani, Mariana [1 ]
Boiani, Lucia [1 ]
Merlino, Alicia [1 ]
Hernandez, Paola [1 ]
Chidichimo, Agustina [2 ]
Cazzulo, Juan J. [2 ]
Cerecetto, Hugo [1 ]
Gonzalez, Mercedes [1 ]
机构
[1] Univ Republica, Fac Quim, Fac Ciencias, Dept Quim Organ, Montevideo 11400, Uruguay
[2] Univ Nacl Gen San Martin, CONICET, Inst Invest Biotecnol, Buenos Aires, DF, Argentina
关键词
2H-Benzimidazole 1,3-dioxide; Chagas disease; Leishmaniasis; Mitochondrial dehydrogenases; N-OXIDE DERIVATIVES; POTENTIAL ANTITRYPANOSOMAL DRUGS; VISCERAL LEISHMANIASIS; CRUZI GROWTH; IN-VITRO; INHIBITORS; METABOLISM; COMPONENTS; IMIDAZOLE; MECHANISM;
D O I
10.1016/j.ejmech.2009.06.014
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
Exploring the influence of different substitution patterns of 2H-benzimidazole 1,3-dioxide derivatives (BzNO) we prepared fifteen new derivatives. Initially the BzNO were tested against Trypanosoma cruzi Tulahuen 2 strain epimastigote form rendering very potent anti-T. cruzi agents. Moreover, the BzNO were able to inhibit the growth of virulent and resistant to Benznidazole strains (CL Brener clone, Colombiana, and Y strains) and to Leishmania braziliensis. Interestingly, BzNO exhibited very high selectivity index and particularly the spiro-BzNO 13 provokes an important diminution of amastigotes in Vero cells. Besides, it was found a diminution of acetate and glycine as excreted metabolites but without increase of parasite glucose uptake indicating that the glycosome is probably not involucrate in the 2H-benzimidazole 1,3-dioxides mechanism of action. (C) 2009 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:4426 / 4433
页数:8
相关论文
共 47 条
[1]
New potent 5-substituted benzofuroxans as inhibitors of Trypanosoma cruzi growth:: Quantitative structure-activity relationship studies [J].
Aguirre, G ;
Boiani, L ;
Boiani, M ;
Cerecetto, H ;
Di Maio, R ;
González, M ;
Porcal, W ;
Denicola, A ;
Piro, OE ;
Castellano, EE ;
Sant'Anna, CMR ;
Barreiro, EJ .
BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (23) :6336-6346
[2]
Benzo[1,2-c]1,2,5-oxadiazole N-oxide derivatives as potential antitrypanosomal drugs.: Part 3:: Substituents-clustering methodology in the search for new active compounds [J].
Aguirre, G ;
Boiani, L ;
Cerecetto, H ;
Di Maio, R ;
González, M ;
Porcal, W ;
Denicola, A ;
Möller, M ;
Thomson, L ;
Tórtora, V .
BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (23) :6324-6335
[3]
Novel antiprotozoal products:: Imidazole and benzimidazole N-oxide derivatives and related compounds [J].
Aguirre, G ;
Bolani, M ;
Cerecetto, H ;
Gerpe, A ;
González, M ;
Sainz, YF ;
Denicola, A ;
de Ocáriz, CO ;
Nogal, JJ ;
Montero, D ;
Escario, JA .
ARCHIV DER PHARMAZIE, 2004, 337 (05) :259-270
[4]
Quinoxaline NN′-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi.: Structure-activity YP relationships [J].
Aguirre, G ;
Cerecetto, H ;
Di Maio, R ;
González, M ;
Alfaro, MEM ;
Jaso, A ;
Zarranz, B ;
Ortega, MA ;
Aldana, I ;
Monge-Vega, A .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (14) :3835-3839
[5]
Aguirre G, 2002, ARCH PHARM, V335, P15, DOI 10.1002/1521-4184(200201)335:1<15::AID-ARDP15>3.0.CO
[6]
2-8
[7]
Trypanosoma cruzi:: Characterization of an intracellular epimastigote-like form [J].
Almeida-de-Faria, M ;
Freymüller, E ;
Colli, W ;
Alves, MJM .
EXPERIMENTAL PARASITOLOGY, 1999, 92 (04) :263-274
[8]
Current treatment approaches to leishmaniasis [J].
Berman, J .
CURRENT OPINION IN INFECTIOUS DISEASES, 2003, 16 (05) :397-401
[9]
Bernacchi AS, 2002, ACTA PHARMACOL SIN, V23, P399
[10]
Furoxan-, alkylnitrate-derivatives and related compounds as anti-trypanosomatid agents:: Mechanism of action studies [J].
Boiani, Lucia ;
Aguirre, Gabriela ;
Gonzalez, Mercedes ;
Cerecetto, Hugo ;
Chidichimo, Agustina ;
Cazzulo, Juan J. ;
Bertinaria, Massimo ;
Guglielmo, Stefano .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (17) :7900-7907